Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
1.
Diabetes Obes Metab ; 18(1): 72-81, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26434748

RESUMO

AIMS: To investigate, for a given energy expenditure (EE) rise, the differential effects of glucagon infusion and cold exposure on brown adipose tissue (BAT) activation in humans. METHODS: Indirect calorimetry and supraclavicular thermography was performed in 11 healthy male volunteers before and after: cold exposure; glucagon infusion (at 23 °C); and vehicle infusion (at 23 °C). All volunteers underwent (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET)/CT scanning with cold exposure. Subjects with cold-induced BAT activation on (18)F-FDG PET/CT (n = 8) underwent a randomly allocated second (18)F-FDG PET/CT scan (at 23 °C), either with glucagon infusion (n = 4) or vehicle infusion (n = 4). RESULTS: We observed that EE increased by 14% after cold exposure and by 15% after glucagon infusion (50 ng/kg/min; p < 0.05 vs control for both). Cold exposure produced an increase in neck temperature (+0.44 °C; p < 0.001 vs control), but glucagon infusion did not alter neck temperature. In subjects with a cold-induced increase in the metabolic activity of supraclavicular BAT on (18)F-FDG PET/CT, a significant rise in the metabolic activity of BAT after glucagon infusion was not detected. Cold exposure increased sympathetic activation, as measured by circulating norepinephrine levels, but glucagon infusion did not. CONCLUSIONS: Glucagon increases EE by a similar magnitude compared with cold activation, but independently of BAT thermogenesis. This finding is of importance for the development of safe treatments for obesity through upregulation of EE.


Assuntos
Tecido Adiposo Marrom/metabolismo , Metabolismo Energético/efeitos dos fármacos , Glucagon/farmacocinética , Adulto , Temperatura Baixa , Estudos Controlados Antes e Depois , Fluordesoxiglucose F18 , Voluntários Saudáveis , Humanos , Masculino , Tomografia por Emissão de Pósitrons/métodos , Distribuição Aleatória , Termogênese/efeitos dos fármacos , Tomografia Computadorizada por Raios X , Adulto Jovem
2.
J Physiol ; 592(23): 5153-67, 2014 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-25217372

RESUMO

Bayliss and Starling first coined the term 'hormone' with reference to secretin, a substance they found that was produced by the gut, but released into the blood stream to act at a distance. The intestine is now known as the largest endocrine organ in the body, and it produces numerous hormones with a wide range of functions. These include controlling appetite and energy homeostasis. Obesity is one of the greatest health threats facing the world today. At present, the only successful treatment is surgery. Bariatric procedures such as the Roux-en-Y bypass work by elevating gut hormones that induce satiety. Significant research has gone into producing versions of these hormones that can be delivered therapeutically to treat obesity. This review looks at the role of gut hormones in obesity, and the development of gut hormone-derived obesity treatments.


Assuntos
Hormônios Gastrointestinais/fisiologia , Hormônios Gastrointestinais/uso terapêutico , Obesidade/fisiopatologia , Obesidade/terapia , Animais , Apetite/fisiologia , Regulação do Apetite/fisiologia , Distinções e Prêmios , Cirurgia Bariátrica , Metabolismo Energético/fisiologia , Feminino , Peptídeo 1 Semelhante ao Glucagon/fisiologia , Peptídeo 1 Semelhante ao Glucagon/uso terapêutico , Humanos , Masculino , Obesidade/epidemiologia , Pandemias , Peptídeo YY/fisiologia , Peptídeo YY/uso terapêutico , Sociedades Científicas
3.
Br J Cancer ; 110(1): 115-22, 2014 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-24231952

RESUMO

BACKGROUND: Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are heterogeneous with respect to biological behaviour and prognosis. As angiogenesis is a renowned pathogenic hallmark as well as a therapeutic target, we aimed to investigate the prognostic and clinico-pathological role of tissue markers of hypoxia and angiogenesis in GEP-NETs. METHODS: Tissue microarray (TMA) blocks were constructed with 86 tumours diagnosed from 1988 to 2010. Tissue microarray sections were immunostained for hypoxia inducible factor 1α (Hif-1α), vascular endothelial growth factor-A (VEGF-A), carbonic anhydrase IX (Ca-IX) and somatostatin receptors (SSTR) 1-5, Ki-67 and CD31. Biomarker expression was correlated with clinico-pathological variables and tested for survival prediction using Kaplan-Meier and Cox regression methods. RESULTS: Eighty-six consecutive cases were included: 51% male, median age 51 (range 16-82), 68% presenting with a pancreatic primary, 95% well differentiated, 51% metastatic. Higher grading (P=0.03), advanced stage (P<0.001), high Hif-1α and low SSTR-2 expression (P=0.03) predicted for shorter overall survival (OS) on univariate analyses. Stage, SSTR-2 and Hif-1α expression were confirmed as multivariate predictors of OS. Median OS for patients with SSTR-2+/Hif-1α-tumours was not reached after median follow up of 8.8 years, whereas SSTR-2-/Hif-1α+ GEP-NETs had a median survival of only 4.2 years (P=0.006). CONCLUSION: We have identified a coherent expression signature by immunohistochemistry that can be used for patient stratification and to optimise treatment decisions in GEP-NETs independently from stage and grading. Tumours with preserved SSTR-2 and low Hif-1α expression have an indolent phenotype and may be offered less aggressive management and less stringent follow up.


Assuntos
Neoplasias Gastrointestinais/irrigação sanguínea , Neoplasias Gastrointestinais/metabolismo , Tumores Neuroendócrinos/irrigação sanguínea , Tumores Neuroendócrinos/metabolismo , Neoplasias Pancreáticas/irrigação sanguínea , Neoplasias Pancreáticas/metabolismo , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Subunidade alfa do Fator 1 Induzível por Hipóxia/biossíntese , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Gradação de Tumores , Estadiamento de Neoplasias , Neovascularização Patológica/metabolismo , Neovascularização Patológica/patologia , Fenótipo , Receptores de Somatostatina/biossíntese , Taxa de Sobrevida , Análise Serial de Tecidos , Adulto Jovem
4.
Mol Metab ; 85: 101947, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38677509

RESUMO

OBJECTIVE: Type 2 diabetes (T2D) is characterised by the loss of first-phase insulin secretion. We studied mice with ß-cell selective loss of the glucagon receptor (Gcgrfl/fl X Ins-1Cre), to investigate the role of intra-islet glucagon receptor (GCGR) signalling on pan-islet [Ca2+]I activity and insulin secretion. METHODS: Metabolic profiling was conducted on Gcgrß-cell-/- and littermate controls. Crossing with GCaMP6f (STOP flox) animals further allowed for ß-cell specific expression of a fluorescent calcium indicator. These islets were functionally imaged in vitro and in vivo. Wild-type mice were transplanted with islets expressing GCaMP6f in ß-cells into the anterior eye chamber and placed on a high fat diet. Part of the cohort received a glucagon analogue (GCG-analogue) for 40 days and the control group were fed to achieve weight matching. Calcium imaging was performed regularly during the development of hyperglycaemia and in response to GCG-analogue treatment. RESULTS: Gcgrß-cell-/- mice exhibited higher glucose levels following intraperitoneal glucose challenge (control 12.7 mmol/L ± 0.6 vs. Gcgrß-cell-/- 15.4 mmol/L ± 0.0 at 15 min, p = 0.002); fasting glycaemia was not different to controls. In vitro, Gcgrß-cell-/- islets showed profound loss of pan-islet [Ca2+]I waves in response to glucose which was only partially rescued in vivo. Diet induced obesity and hyperglycaemia also resulted in a loss of co-ordinated [Ca2+]I waves in transplanted islets. This was reversed with GCG-analogue treatment, independently of weight-loss (n = 8). CONCLUSION: These data provide novel evidence for the role of intra-islet GCGR signalling in sustaining synchronised [Ca2+]I waves and support a possible therapeutic role for glucagonergic agents to restore the insulin secretory capacity lost in T2D.


Assuntos
Diabetes Mellitus Tipo 2 , Glucagon , Glucose , Homeostase , Secreção de Insulina , Células Secretoras de Insulina , Receptores de Glucagon , Transdução de Sinais , Animais , Glucagon/metabolismo , Camundongos , Células Secretoras de Insulina/metabolismo , Glucose/metabolismo , Receptores de Glucagon/metabolismo , Receptores de Glucagon/genética , Diabetes Mellitus Tipo 2/metabolismo , Insulina/metabolismo , Masculino , Ilhotas Pancreáticas/metabolismo , Camundongos Endogâmicos C57BL , Camundongos Knockout , Dieta Hiperlipídica , Glicemia/metabolismo , Feminino
5.
Br J Cancer ; 108(2): 429-37, 2013 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-23257898

RESUMO

BACKGROUND: There are no reliable markers of malignancy in phaeochromocytomas (PCC) and paragangliomas (PGL). We investigated the relevance of the mammalian target of rapamycin (mTOR)/AKT and hypoxic pathways as novel immunohistochemical markers of malignancy. METHODS: Tissue microarray blocks were constructed with a total of 100 tumours (10 metastatic) and 20 normal adrenomedullary samples. Sections were immunostained for hypoxia-inducible factor 1α (Hif-1α), vascular endothelial growth factor A (VEGF-A), mTOR, carbonic anhydrase IX (CaIX) and AKT. The predictive performance of these markers was studied using univariate, multivariate and receiver operating characteristic analyses. RESULTS: In all, 100 consecutive patients, 64% PCC, 29% familial with a median tumour size of 4.7 cm (range 1-14) were included. Univariate analyses showed Hif-1α overexpression, tumour necrosis, size >5 cm, capsular and vascular invasion to be predictors of metastasis. In multivariate analysis, Hif-1α, necrosis and vascular invasion remained as independent predictors of metastasis. Hif-1α was the most discriminatory biomarker for the presence of metastatic diffusion. Strong membranous CaIX expression was seen in von Hippel-Lindau (VHL) PCC as opposed to other subtypes. CONCLUSION: Lack of vascular invasion, tumour necrosis and low Hif-1α expression identify tumours with lower risk of malignancy. We propose membranous CaIX expression as a potential marker for VHL disease in patients presenting with PCC.


Assuntos
Antígenos de Neoplasias/análise , Anidrases Carbônicas/análise , Subunidade alfa do Fator 1 Induzível por Hipóxia/análise , Paraganglioma/química , Paraganglioma/genética , Feocromocitoma/química , Feocromocitoma/genética , Proteína Supressora de Tumor Von Hippel-Lindau/genética , Neoplasias das Glândulas Suprarrenais/diagnóstico , Neoplasias das Glândulas Suprarrenais/genética , Neoplasias das Glândulas Suprarrenais/imunologia , Adulto , Antígenos de Neoplasias/imunologia , Biomarcadores Tumorais/análise , Biomarcadores Tumorais/genética , Biomarcadores Tumorais/imunologia , Anidrase Carbônica IX , Anidrases Carbônicas/imunologia , Hipóxia Celular , Feminino , Mutação em Linhagem Germinativa , Humanos , Subunidade alfa do Fator 1 Induzível por Hipóxia/imunologia , Imuno-Histoquímica , Masculino , Metástase Neoplásica , Paraganglioma/diagnóstico , Feocromocitoma/diagnóstico , Proteínas Proto-Oncogênicas c-akt/análise , Proteínas Proto-Oncogênicas c-akt/imunologia , Serina-Treonina Quinases TOR/análise , Serina-Treonina Quinases TOR/imunologia , Análise Serial de Tecidos , Fator A de Crescimento do Endotélio Vascular/análise , Fator A de Crescimento do Endotélio Vascular/imunologia , Doença de von Hippel-Lindau/diagnóstico , Doença de von Hippel-Lindau/genética
6.
Peptides ; 162: 170962, 2023 04.
Artigo em Inglês | MEDLINE | ID: mdl-36736539

RESUMO

Glucagon receptor (GCGR)-targeted multi-agonists are being developed for the treatment of obesity and metabolic disease. GCGR activity is utilised for its favourable weight loss and metabolic properties, including increased energy expenditure (EE) and hepatic lipid metabolism. GLP1R and GIPR activities are increasingly present in a multi-agonist strategy. Due to the compound effect of increased satiety, reduced food intake and increased energy expenditure, the striking weight loss effects of these multi-agonists has been demonstrated in pre-clinical models of obesity. The precise contribution and mechanism of GCGR activity to enhanced energy expenditure and weight loss in both rodents and humans is not fully understood. In this review, our understanding of glucagon-mediated EE is explored, and an amino acid-centric paradigm contributing to this phenomenon is presented. The current progress of GCGR-targeted multi-agonists in development is also highlighted with a focus on the implications of glucagon-stimulated hypoaminoacidemia.


Assuntos
Glucagon , Receptores de Glucagon , Humanos , Glucagon/metabolismo , Receptores de Glucagon/metabolismo , Obesidade/metabolismo , Redução de Peso , Metabolismo Energético , Aminoácidos , Receptor do Peptídeo Semelhante ao Glucagon 1/metabolismo
7.
Infect Agent Cancer ; 18(1): 5, 2023 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-36726132

RESUMO

OBJECTIVE: To study the potential mechanism of Lactobacillus crispatus inhibiting cervical squamous intraepithelial lesion (SIL) and screen the early warning factors of SIL. METHODS: The effects of Lactobacillus crispatus on the proliferation, apoptosis, cross pore migration and invasion and cytokines of cervical precancerous cells Ect1/E6E7 were detected respectively. The effect of Lactobacillus crispatus on the expression of differential proteins screened in Ect1/E6E7 cells were detected by Western blot. RESULTS: Lactobacillus crispatus significantly inhibited the proliferation, induced apoptosis and inhibited cell migration of Ect1/E6E7 cells in a time-dependent manner (P < 0.05), but had no significant effect on cell invasion. Lactobacillus crispatus significantly promoted the secretion of Th1 cytokines and inhibited the secretion of Th2 cytokines by Ect1/E6E7 cells (P < 0.05). In addition, compared with SiHa cells in the control group, the expression of differential proteins PCNA, ATM, LIG1 and HMGB1 in Ect1/E6E7cells decreased significantly, while the expression of TDG and OGG1 proteins increased significantly (P < 0.05). ABCG2 protein in Ect1/E6E7 cells was slightly higher than that in SiHa cells, but the difference was not statistically significant. What is interesting is that Lactobacillus crispatus significantly inhibited the expression of ABCG2, PCNA, ATM, LIG1, OGG1 and HMGB1 proteins in Ect1/E6E7 cells, and promoted the expression of TDG protein. CONCLUSIONS: Lactobacillus crispatus may inhibit the function of Ect1/E6E7 cells through multiple pathways and exert the potential to reverse the progression of SIL.

8.
Cancer Res ; 55(20): 4599-605, 1995 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-7553636

RESUMO

Human cervical cancers are often associated with human papillomavirus (HPV). In HPV-positive cervical cancers, the oncoproteins E6 and E7 are consistently expressed. In this study, the effects of antisense inhibition of both proteins were examined. Phosphorothioate oligonucleotides (ODNs) AE6 and AE7 complementary to regions flanking the start codons of HPV16 E6 and E7 genes, respectively, were synthesized. These anti-HPV ODNs inhibited the growth of cervical cell lines CaSki and SiHa, which harbor HPV16 but had little effect on cells that do not. Both ODNs also affected the ability of CaSki cells to form colonies in soft agar. In nude mice, treatment with either AE6, AE7, or a mixture of both led to substantially smaller tumors. AE7 was observed to inhibit E7 synthesis. The AE6 ODN probably exerts its effect by suppressing the expression of E6 as well as E7. Cell cultures and tumors treated with AE6 showed a decrease in E7 expression. In addition, an antisense ODN targeted at the retinoblastoma gene was able to reverse some of the inhibitory effect of AE6 on CaSki cells, indicating that AE6 inhibited E7 synthesis. This study further demonstrates that anti-HPV ODNs may be useful therapeutically.


Assuntos
Regulação Viral da Expressão Gênica , Genes Virais , Papillomaviridae/genética , Proteínas Repressoras , Neoplasias do Colo do Útero/virologia , Proteínas Estruturais Virais/genética , Animais , Antineoplásicos/farmacologia , Sequência de Bases , Adesão Celular , Feminino , Inibidores do Crescimento/farmacologia , Humanos , Técnicas In Vitro , Camundongos , Camundongos Nus , Dados de Sequência Molecular , Transplante de Neoplasias , Oligonucleotídeos Antissenso/química , Oligonucleotídeos Antissenso/farmacologia , Proteínas Oncogênicas Virais/metabolismo , Proteínas E7 de Papillomavirus , RNA Mensageiro/genética , Proteína do Retinoblastoma/metabolismo , Células Tumorais Cultivadas , Neoplasias do Colo do Útero/patologia
9.
Gene ; 200(1-2): 91-8, 1997 Oct 24.
Artigo em Inglês | MEDLINE | ID: mdl-9373142

RESUMO

The murine malaria parasite Plasmodium berghei contains a plastid-like extrachromosomal genome. This genome is 30.7 kb in size and is transcriptionally active as shown by RT-PCR. DNA sequence analysis of the genome reveals 69.9-95.5% homology to sequences of the 35-kb extrachromosomal circle found in the human malaria species Plasmodium falciparum. Homologous sequences include regions of genes for the ssu-rRNA, lsu-rRNA, rpo B and clusters of t-RNAs. Sequence variation between the two Plasmodium species exists in the non-coding interspacing regions. A physical map has been constructed for the P. berghei circle, indicating the EcoRI and HindIII restriction sites as well as the arrangement of the rRNA, rpo B and tRNA genes. Arrangement of these genes is similar to that found on the P. falciparum 35-kb circle. The P. berghei circular element is distinct from the mitochondrial 6-kb DNA of both the murine and the human Plasmodium species. Preliminary results indicate that the circle may be a useful target for drug therapy.


Assuntos
DNA de Protozoário/química , Plasmodium berghei/genética , Animais , Sequência de Bases , DNA Mitocondrial/química , DNA Mitocondrial/genética , DNA de Protozoário/genética , DNA de Protozoário/ultraestrutura , Variação Genética , Humanos , Camundongos , Plasmodium falciparum/genética , Plastídeos/ultraestrutura , Reação em Cadeia da Polimerase , RNA de Protozoário/biossíntese , Mapeamento por Restrição , Homologia de Sequência do Ácido Nucleico
10.
Free Radic Biol Med ; 31(5): 659-69, 2001 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-11522451

RESUMO

Peroxisome proliferators have been found to induce hepatocarcinogenesis in rodents, and may cause mitochondrial damage. Consistent with this, clofibrate increased hepatic mitochondrial oxidative DNA and protein damage in mice. The present investigation aimed to study the mechanism by which this might occur by examining the effect of clofibrate on freshly isolated mouse liver mitochondria and a cultured hepatocyte cell line, AML-12. Mitochondrial membrane potential (Delta Psi(m)) was determined by using the fluorescent dye 5,5',6,6'-tetrachloro-1,1', 3,3'-tetraethyl-benzimidazolylcarbocyanine iodide (JC-1) and tetramethylrhodamine methyl ester (TMRM). Application of clofibrate at concentrations greater than 0.3 mM rapidly collapsed the Delta Psi(m) both in liver cells and in isolated mitochondria. The loss of Delta Psi(m) occurred prior to cell death and appeared to involve the mitochondrial permeability transition (MPT), as revealed by calcein fluorescence studies and the protective effect of cyclosporin A (CsA) on the decrease in Delta Psi(m). Levels of reactive oxygen species (ROS) were measured with the fluorescent probes 5-(and-6)-carboxy-2',7'-dichlorofluorescein diacetate (DCFDA) and dihydrorhodamine 123 (DHR123). Treatment of the hepatocytes with clofibrate caused a significant increase in intracellular and mitochondrial ROS. Antioxidants such as vitamin C, deferoxamine, and catalase were able to protect the cells against the clofibrate-induced loss of viability, as was CsA, but to a lesser extent. These results suggest that one action of clofibrate might be to impair mitochondrial function, so stimulating formation of ROS, which eventually contribute to cell death.


Assuntos
Anticolesterolemiantes/toxicidade , Clofibrato/toxicidade , Hepatócitos/efeitos dos fármacos , Canais Iônicos , Fígado/fisiologia , Mitocôndrias Hepáticas/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Animais , Sobrevivência Celular , Células Cultivadas , Ciclosporina/farmacologia , Radicais Livres , Hepatócitos/metabolismo , Potenciais da Membrana/fisiologia , Proteínas de Membrana/metabolismo , Camundongos , Mitocôndrias Hepáticas/metabolismo , Proteínas de Transporte da Membrana Mitocondrial , Poro de Transição de Permeabilidade Mitocondrial , Espécies Reativas de Oxigênio/metabolismo
11.
Int J Radiat Oncol Biol Phys ; 11(7): 1313-6, 1985 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-4008288

RESUMO

The results of 322 patients with uterine cervix carcinoma treated by radiotherapy at the Singapore General Hospital in the 3-year period from 1973 to 75 are presented. Two hundred seventy-nine patients were treated with a combination of intracavitary radium, using Fletcher-Suit applicators and cobalt teletherapy; the remaining 43 patients received only cobalt teletherapy. One hundred thirty-four patients (41.6%) presented with FIGO Stage III disease. Only 46 patients (14.3%) presented with Stage I disease, showing that patients tended to present late in the disease course. Five-year actuarial (uncorrected) survival rates of 86.7% for Stage I, 65.0% for Stage II, 41.4% for Stage III and 4.9% for Stage IV were obtained with corresponding 10 year rates of 79.6%, 60.2%, 35.2% and 0%. The overall 5 and 10 year survival rates were 54.0% and 48.2%, respectively. The survival rates "flattened off" at about 7-8 years, reflecting late deaths after the fifth anniversary of treatment. Non-severe complications consisted mainly of chronic proctitis (41.3%) and vaginal stenosis (20.8%). Major complications were intestinal stricture (1.2%) and fistula formation (1.6%).


Assuntos
Neoplasias do Colo do Útero/radioterapia , Adulto , Idoso , Braquiterapia , Radioisótopos de Cobalto/uso terapêutico , Feminino , Humanos , Pessoa de Meia-Idade , Recidiva Local de Neoplasia , Prognóstico , Teleterapia por Radioisótopo , Radioterapia/efeitos adversos , Rádio (Elemento)/uso terapêutico
12.
Biochem Pharmacol ; 37(24): 4629-33, 1988 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-3202900

RESUMO

Sulphate conjugation was investigated using extracts of human foetal liver cells in culture. The three reactions which are involved in sulphate conjugation were measured singly or in combination: they are (i) the PAPS generation catalyzed by ATP-sulphurylase and adenosine 5'-phosphosulphate (APS)-kinase, (ii) the phenolsulphotransferase (PST) reaction, and (iii) the overall sulphate conjugation which comprises the above three reactions. All were radiometric assays employing PAP35S or sodium 35sulphate. N-acetyldopamine (NADA) was the substrate of choice although the reactions were also demonstrated with dopamine and 1-naphthol. Kinetic studies with NADA showed two pH optima of 6.7 and 8.6 for the overall sulphate conjugation and the PST reaction while the PAPS generation occurred maximally at pH 8.0. The apparent Km value for NADA measured by both the PST and the overall sulphate conjugation reactions was the same, being 38 microM, while that for inorganic sulphate, of 107 microM and 240 microM (measured by the overall sulphate conjugation reactions and by PAPS generation, respectively) was two orders of magnitude higher than that of PAPS, which was 2.57 microM. It was possible to maintain a relatively constant level of the three activities of sulphate conjugation in confluent, quiescent cultures. The importance of sulphate conjugation for detoxification in foetal cells is discussed.


Assuntos
Arilsulfotransferase/metabolismo , Fígado/metabolismo , Trifosfato de Adenosina/metabolismo , Células Cultivadas , Dopamina/metabolismo , Humanos , Concentração de Íons de Hidrogênio , Técnicas In Vitro , Cinética , Fígado/embriologia , Fosfoadenosina Fosfossulfato/metabolismo , Fatores de Tempo
13.
Acta Trop ; 68(1): 105-14, 1997 Oct 14.
Artigo em Inglês | MEDLINE | ID: mdl-9352006

RESUMO

The Plasmodium parasite possesses two extrachromosomal genomes; the mitochondrial genetic element and the extrachromosomal plastid-like DNA. The latter has only been fully described for one culture strain of P. falciparum. In this study, a rapid procedure for amplifying plastid DNA from dried blood spots of blood infected with different malaria species was developed. PCR amplification of a 595 bp fragment within the plastid-like large subunit ribosomal-RNA (LSU-rRNA) gene was achieved using primers derived from the P. falciparum sequence. The PCR product was observed in all Plasmodium species examined. Sequence analysis of amplified products homologous to an LSU-rRNA fragment of the plastid-like extrachromosomal circle revealed extensive conservation between Plasmodium species including P. falciparum, P. vivax, P. malariae and P. berghei.


Assuntos
DNA de Protozoário/sangue , Plasmodium/genética , Reação em Cadeia da Polimerase , Animais , Sequência de Bases , DNA de Protozoário/química , Humanos , Dados de Sequência Molecular , RNA Ribossômico/química , Alinhamento de Sequência
14.
J Neural Transm Suppl ; 29: 163-71, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2193106

RESUMO

Sulfate conjugation in vitro was studied in a number of human tissues, such as the platelets, liver as well as in human foetal liver cells in culture. Essentially, the two enzymes involved in PAPS generation and PST were measured either singly or in combination, representing PAPS generation, PST and the overall three-step sulfate conjugation. These activities in the liver and platelets were comparable in magnitude. In the platelets, PAPS generation and PST activities showed a good correlation to the overall sulfate conjugation. With the expression of these activities in human foetal liver cells in culture, it is anticipated that such cells can be employed as model systems for the study of sulfate conjugation in man.


Assuntos
Nucleotídeos de Adenina/metabolismo , Arilsulfotransferase/metabolismo , Plaquetas/metabolismo , Catecolaminas/metabolismo , Fígado/metabolismo , Fosfoadenosina Fosfossulfato/metabolismo , Humanos
15.
Toxicology ; 64(1): 81-7, 1990 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-2120797

RESUMO

Administration of mercuric chloride to young adult mice produced a significant increase in the activity of renal UDP-glucuronyltransferase (UDPGT) measured with harmol as the acceptor substrate. This was observed 10 days after a daily oral dose of HgCl2 (6 micrograms Hg2+/g body wt.). The increase in UDPGT activity was correlated with an accumulation of mercury in the renal tissues and was accompanied by an increase in the apparent Vmax of the glucuronidation reaction without a change in the apparent Km values for harmol or UDPGA. Parallel studies with mercuric sulfide however showed negligible retention of mercury in both the liver or kidney nor was there any change in UDPGT activity compared to control values. The difference in solubilities of the two mercuric salts may be responsible for this observation. The possible mode of activation of UDPGT by mercury treatment is discussed.


Assuntos
Glucuronosiltransferase/metabolismo , Rim/efeitos dos fármacos , Cloreto de Mercúrio/toxicidade , Compostos de Mercúrio , Mercúrio/toxicidade , Animais , Feminino , Rim/química , Rim/enzimologia , Fígado/química , Fígado/efeitos dos fármacos , Fígado/enzimologia , Mercúrio/análise , Camundongos , Solubilidade
16.
Ann Acad Med Singap ; 17(1): 19-21, 1988 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-3190155

RESUMO

This study analyses the results of primary radiotherapy for 44 patients with early glottic cancer (Tis, T1 stage) given at the Therapeutic Radiology Department, Singapore General Hospital during the 4-year period from 1978 to 1981. Irradiation was delivered using cobalt teletherapy with free set-ups, and without "air-gap" compensation. Total doses of 55Gy to 64Gy were given in daily fractions of 1.8Gy, treating five times a week. The crude 5-year survival rate for Tis/T1a tumours was 88.9% and for T1b lesions, 81%. On correcting for deaths from intercurrent disease, the survival rates improved to 95.5% and 92.6% respectively. In 33 cases where the quality of voice after radiation was assessed, 15 patients (45.4%) retained good voice quality with an additional 11 patients (33.3%) having acceptable voice quality. In seven cases the voice after radiation was rated as poor. Nine patients had local recurrence, giving a rate of 20.4%. One other patient had cervical node metastasis and subsequently developed lung secondaries. Surgery, solely or with re-irradiation, was an effective treatment for local recurrence. Re-irradiation alone failed to control any case with recurrence.


Assuntos
Carcinoma de Células Escamosas/radioterapia , Radioisótopos de Cobalto/uso terapêutico , Glote , Neoplasias Laríngeas/radioterapia , Teleterapia por Radioisótopo , Carcinoma de Células Escamosas/mortalidade , Feminino , Humanos , Neoplasias Laríngeas/mortalidade , Masculino , Pessoa de Meia-Idade , Dosagem Radioterapêutica , Singapura
17.
Ann Acad Med Singap ; 16(3): 441-3, 1987 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-3435011

RESUMO

The results of 76 cases of advanced colorectal carcinoma treated at the Department of Therapeutic Radiology, Singapore General Hospital, from 1977 to 1978, are presented. All cases had "Curative" Surgery and were given adjuvant radiotherapy or chemotherapy or both. All were adenocarcinoma and had lymph node involvement as well as tumour infiltration through the bowel wall. 44 cases of rectal carcinoma were given radiotherapy to the pelvis followed by I/V 5-fluorouracil for at least one year. 32 cases of colon cancer were given I/V 5-fluorouracil for at least one year. 20 of these cases had cancer of the sigmoid colon and were given pelvic irradiation as well. The five year actuarial survival rates were 27.8% for rectal cancer and 24.3% for colon cancer.


Assuntos
Adenocarcinoma/mortalidade , Carcinoma/mortalidade , Neoplasias do Colo/mortalidade , Neoplasias Retais/mortalidade , Análise Atuarial , Adenocarcinoma/tratamento farmacológico , Adenocarcinoma/radioterapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma/tratamento farmacológico , Carcinoma/radioterapia , Neoplasias do Colo/tratamento farmacológico , Neoplasias do Colo/radioterapia , Terapia Combinada , Feminino , Fluoruracila/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Dosagem Radioterapêutica , Neoplasias Retais/tratamento farmacológico , Neoplasias Retais/radioterapia , Estudos Retrospectivos , Singapura
20.
Surg Today ; 29(8): 828-31, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10483770

RESUMO

This study was conducted to evaluate the efficiency of polymeric clips in minimally invasive surgery. Absorbable polymeric clips were applied to the cystic duct, appendicular stump, and blood vessels in 35 patients undergoing laparoscopic or thoracoscopic procedures. All patients were reviewed 3 months after their operations, and no complications related to the clips were observed. These findings indicate that absorbable clips have more advantages than metallic clips. We believe that as this clip is easy to operate with safety, it should be used in the majority of minimally invasive surgical procedures.


Assuntos
Hemostasia Cirúrgica/instrumentação , Procedimentos Cirúrgicos Minimamente Invasivos/instrumentação , Humanos , Teste de Materiais , Ácido Poliglicólico , Polímeros , Titânio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA